SNT 25.7% 4.4¢ syntara limited

new money, page-49

  1. 441 Posts.
    lightbulb Created with Sketch. 7
    at least company has funding certainty and an approved product on market in EU and AUS with revenues growing.

    Is FDA knockback first time around so surprising given bronchitol was initially rejected by the EMA? I'm confident pharmaxis will overcome this setback and bronchitol will gain entry to the US.

    Good buying opportunity here - I am back in now. Patience on this one though.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
0.009(25.7%)
Mkt cap ! $52.53M
Open High Low Value Volume
3.6¢ 4.4¢ 3.6¢ $183.9K 4.656M

Buyers (Bids)

No. Vol. Price($)
1 1159 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 997342 3
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.